ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Exo Therapeutics Logo

Exo Therapeutics

Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSight™ platform, we are developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect.

Quick overview

Cambridge, United States

Additional information

Working industry

Other

Type of company

-

Locations

1 Headquarter

Specialised areas

Biotechnology, Health Care, Pharmaceutical

ESG score estimation

An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself

Country:

United States


Overall risk estimation:

Low


ESG country scores

The ESG Data of countries are based on public sources

Environment

D

Grade (A-E)

View details

Social

A

Grade (A-E)

View details

Governance

A

Grade (A-E)

View details

Headquarter of Exo Therapeutics

Exo Therapeutics operates in 1 country around the world

City: Cambridge

State: Massachusetts

Country: United States

Locations of Exo Therapeutics

Get an overview of the locations of Exo Therapeutics

Location

Country

State

City

Headquarter

United States

Massachusetts

Cambridge

Frequently asked questions (FAQ) about Exo Therapeutics

Some frequent questions that have been asked about Exo Therapeutics

The company headquarter of Exo Therapeutics is located in Cambridge, Massachusetts, United States. It's worth noting, that the company may have more locations

The company Exo Therapeutics has it's main focus in the industries of Other

Competitors of Exo Therapeutics

Check out some interesting alternative companies to Exo Therapeutics

EXO Biologics's Logo

EXO Biologics

Niel, Belgium

11-50 Employees

2019

At EXO Biologics, we are united around our belief in the therapeutic potential of Exosomes. Our mission is to provide affordable and accessible therapy to patients with unmet medical needs. We are on a fully integrated site that houses our research, development, and production facilities. We are developing our production platform to load exosomes with therapeutic molecules, such as RNAs, proteins, and chemical drug compounds, for safer and more effective targeted therapies. Founded in Liège in 2019, EXO Biologics works closely with Professor M. At EXO Biologics, we have successfully overcome the challenge of consistent and large-scale production by internally developing a unique production platform. We believe innovation and collaboration are essential to driving progress in exosome therapy. That's why our team comprises highly skilled multidisciplinary scientists dedicated to advancing our understanding and production of exosomes.

Expansion Therapeutics's Logo

Expansion Therapeutics

San Diego, United States

11-50 Employees

2016

We are a team in relentless pursuit of game changing solutions in human health. We believe that the development of small molecule drugs that modulate RNA will dramatically change patient outcomes for diseases where treatment options for patients are currently limited. Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Our team's work is founded upon leading research emerging from Scripps Research.

TargetEx Biosciences Ltd.'s Logo

TargetEx Biosciences Ltd.

Budapest, Hungary

11-50 Employees

2002

TargetEx (formerly known as RecomGenex) was founded in 2002 by an integrated discovery chemistry provider who teamed up with academic researchers with expertise in recombinant technologies. In 2007 TargetEx became an independent company offering complex services in the early phase of drug discovery. TargetEx’ another new business line is the production of various enzymes for kits used in molecular biology and human diagnostics. In 2018 we established an ISO 9001 quality control management system for recombinant protein production, purification and analytics. To provide superior services for biotechnology, health-care and drug discovery.

Exotopic's Logo

Exotopic

City of Westminster, United Kingdom

1-10 Employees

2014

Exotopic is growing the Science and Technology sector by investing in the development of new capabilities, services and skills. If your mission requires innovation… involves complexity… is seeking to break new ground… your mission is Exotopic’s mission. You can focus on tackling the subject matter whilst Exotopic clears the path to market.

Kinetic Discovery Ltd.'s Logo

Kinetic Discovery Ltd.

Dundee, United Kingdom

11-50 Employees

2008

Exscientia AI systems are better at learning than traditional human-led design allowing molecules to reach the clinic faster. Exscientia AI directly challenges this metric by requiring each newly designed molecule to add the maximum information and shorten the path to a clinical molecule. At Exscientia we put AI algorithms at the heart of design and data interpretation. Our mission is to design and develop novel, precision engineered drugs with an improved probability of clinical success for the benefit of patients. We are a creative, passionate and collaborative organisation dedicated to setting bold new standards in drug discovery and design. Finding faster and smarter ways to discover new and better drugs is what drives Exscientia. To address this challenge, we are re-imagining the way drug discovery is implemented, combining the latest AI technique with experimental innovation to engineer a new set of processes for drug discovery.Founded in 2012, we are leading the development of a new discipline; pharmatech, which is at the interface of advanced AI application and complex drug discovery. As a full stack AI drug discovery company, we focus on implementing AI design as well as precision data generation.

neoX Biotech's Logo

neoX Biotech

Beijing, China

11-50 Employees

2018

neoX is a biotech company that combines artificial intelligence (AI) with biophysics for drug research and development. neoX focuses on the research and development of macromolecular drugs and multispecific drugs, especially in the field of immuno-oncology. It has developed a sophisticated platform for early discovery of therapeutics by characterizing protein-protein interactions (PPI). neoX has established cooperation with biomedical companies globally to accelerate drug R&D pipelines.